|
Re: Covid study
|
4
|
Resverlogix Corp.
|
Feb 14, 2024 12:17PM
|
|
Re: Covid study
|
6
|
Resverlogix Corp.
|
Feb 14, 2024 12:28PM
|
|
Re: Covid China
|
8
|
Resverlogix Corp.
|
Mar 29, 2022 07:13PM
|
|
Re: Covid 19 trial
|
6
|
Resverlogix Corp.
|
Jun 04, 2021 11:32AM
|
|
Re: COVID 19 / varients
|
5
|
Resverlogix Corp.
|
Apr 10, 2022 08:45PM
|
|
Re: COVID 19 / varients
|
7
|
Resverlogix Corp.
|
Apr 10, 2022 08:58PM
|
|
Re: COVID 19 / varients
|
3
|
Resverlogix Corp.
|
Apr 11, 2022 10:12AM
|
|
Re: COVID 19 / varients
|
6
|
Resverlogix Corp.
|
Apr 11, 2022 02:19PM
|
|
Re: COVID 19 - Standard of Care
|
6
|
Resverlogix Corp.
|
Apr 22, 2021 03:18PM
|
|
Re: COVID 19 - Standard of Care
|
3
|
Resverlogix Corp.
|
Apr 22, 2021 04:33PM
|
|
Re: COVID 19 & BP
|
1
|
Resverlogix Corp.
|
Jun 27, 2020 10:25PM
|
|
Re: Could you imagine
|
|
Resverlogix Corp.
|
May 25, 2024 01:25PM
|
|
Re: Could it be
|
1
|
Resverlogix Corp.
|
Oct 27, 2023 10:55AM
|
|
Re: Corporate Update Webcast and Conference Call December 16, 2021 @ 2 PM MST
|
9
|
Resverlogix Corp.
|
Dec 13, 2021 09:47AM
|
|
Re: Corporate Update Webcast and Conference Call December 16, 2021 @ 2 PM MST
|
4
|
Resverlogix Corp.
|
Dec 13, 2021 12:35PM
|
|
Re: Corporate Update Webcast and Conference Call December 16, 2021 @ 2 PM MST
|
3
|
Resverlogix Corp.
|
Dec 13, 2021 12:50PM
|
|
Re: Corporate Update Webcast and Conference Call December 16, 2021 @ 2 PM MST
|
6
|
Resverlogix Corp.
|
Dec 13, 2021 02:46PM
|
|
Re: Corporate Update Webcast and Conference Call December 16, 2021 @ 2 PM MST
|
7
|
Resverlogix Corp.
|
Dec 15, 2021 11:47AM
|
|
Re: Corporate Breakthroughs...?
|
|
Resverlogix Corp.
|
Feb 04, 2021 11:59AM
|
|
Re: Context on Sales Potential for an oral anti-viral & anti-inflammation combo
|
6
|
Resverlogix Corp.
|
Apr 14, 2021 10:45PM
|
